CIENCE CIENCEa graph8 company
+ New search
Your company
24 companies like Attralus
Attralus logo

Attralus

attralus.com
Attralus is a clinical-stage biopharmaceutical company developing pan-amyloid removal (PAR) therapeutics that bind to and remove toxic amyloid in organs and tissues, targeting all types and stages of systemic amyloidosis.
ECSSSBRSJSGFKVAV
11-50 emp
337 Bch Rd, Naples, Florida
$10 Million to 25 Million revenue
Biotechnology Research
NAICS 541714
1573•••••93
TECH STACK
CloudflareCookieYesDownload MonitorEasy Pie ChartFitVids.JSGoogle AnalyticsGoogle Tag ManagerHTTP/3MySQLPHPSite KitWP Engine
Attralus campaignconsultative3000 target
Companies like Attralus — Biotechnology Research, 11-50
“Focus on partnering and pipeline expansion for rare disease organizations seeking differentiated amyloid-targeting therapeutic platforms.”
Launch outbound on autopilot

Personalised emails written for every contact · 97% deliverability · live in 60 seconds

Companies 10
Decision-makers 19
Emails 19
Signals 0

Companies like Attralus — competitors and alternatives

CompanyWhat they doLocationSizeHiring
Attralusattralus.com
RSSBSS
Attralus is a clinical-stage biopharmaceutical company developing pan-amyloid removal (PAR) therapeutics that bind to and remove tNaples, Florida11-50
WGMLKJ
Alnylam is a leading independent biopharmaceutical company and the pioneer in RNAi therapeutics, developing medicines that silenceCambridge, Massachusetts1001-5000
CSMDJB
Acorai is a medical device company developing the Acorai Heart Monitor, a non-invasive cardiac and pulmonary pressure sensing syst
Amyloidosisresearchamyloidosisresearch.org
Prothenaprothena.com
BCDZKQ
Prothena is a biopharmaceutical company developing a pipeline of novel therapeutics targeting protein dysregulation in neurodegene
MBMPSM
Foldax is a medical device company developing a lifetime-durability heart valve portfolio — surgical and transcatheter valves builSalt Lake City, Utah11-50
The Amyloidosis Foundationamyloidosis.org
MO
The Amyloidosis Foundation is a nonprofit patient support and education organization founded in 2003 that increases awareness of aIndependence Township, Michigan1-10
NeoPharmneopharm.com
EASUJW
NeoPharm is a publicly traded biopharmaceutical company researching, developing, and commercializing drugs for treating various caNew York, New York11-50
Amyloidtechamyloidtech.com
Run live for more

Agent activity

Done
$fetch_profileattralus.com
Found: Attralus
$analyze_identityattralus.com
Attralus is a clinical-stage biopharmaceutical company developing pan-amyloid removal (PAR) therapeutics that bind to and remove toxic amyloid in organs and tissues, targeting all
$search_companiescompanies like Attralus
24 companies
$search_peopledecision-makers

Frequently asked questions about Attralus

What does Attralus do?

Attralus is a clinical-stage biopharmaceutical company developing pan-amyloid removal (PAR) therapeutics that bind to and remove toxic amyloid in organs and tissues, targeting all types and stages of systemic amyloidosis.

Who are Attralus's competitors?

Companies like Attralus include Alnylam, Acorai, Amyloidosisresearch, Amyloid, Prothena. See the full list of 24 competitors and alternatives above.

How many employees does Attralus have?

Attralus has approximately 11-50 employees and is in the Biotechnology Research industry.

Where is Attralus headquartered?

Attralus is headquartered in Naples, Florida.

What industry is Attralus in?

Attralus operates in the Biotechnology Research industry.

Who are the decision-makers at Attralus?

Key decision-makers and buying contacts at Attralus are listed above, including leaders across executive, finance, sales and operations.